Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity

Douglas G. Gold, Robert C. Miller, Melva E. Pinn, Thomas Osborn, Ivy A Petersen, Paul D. Brown

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

Original languageEnglish (US)
Pages (from-to)127-131
Number of pages5
JournalRadiotherapy and Oncology
Volume87
Issue number1
DOIs
StatePublished - Apr 2008

Fingerprint

Systemic Scleroderma
Systemic Lupus Erythematosus
Connective Tissue
Radiotherapy
Radiation

Keywords

  • Adverse effects
  • Connective tissue disorder
  • Radiotherapy
  • Scleroderma
  • Systemic lupus erythematosus
  • Systemic sclerosis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Cite this

Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus : Association with connective tissue disorder severity. / Gold, Douglas G.; Miller, Robert C.; Pinn, Melva E.; Osborn, Thomas; Petersen, Ivy A; Brown, Paul D.

In: Radiotherapy and Oncology, Vol. 87, No. 1, 04.2008, p. 127-131.

Research output: Contribution to journalArticle

@article{b94cb261941f45bd8ee827fa82ccf68b,
title = "Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity",
abstract = "No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.",
keywords = "Adverse effects, Connective tissue disorder, Radiotherapy, Scleroderma, Systemic lupus erythematosus, Systemic sclerosis",
author = "Gold, {Douglas G.} and Miller, {Robert C.} and Pinn, {Melva E.} and Thomas Osborn and Petersen, {Ivy A} and Brown, {Paul D.}",
year = "2008",
month = "4",
doi = "10.1016/j.radonc.2007.11.031",
language = "English (US)",
volume = "87",
pages = "127--131",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus

T2 - Association with connective tissue disorder severity

AU - Gold, Douglas G.

AU - Miller, Robert C.

AU - Pinn, Melva E.

AU - Osborn, Thomas

AU - Petersen, Ivy A

AU - Brown, Paul D.

PY - 2008/4

Y1 - 2008/4

N2 - No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

AB - No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

KW - Adverse effects

KW - Connective tissue disorder

KW - Radiotherapy

KW - Scleroderma

KW - Systemic lupus erythematosus

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=41949129417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949129417&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2007.11.031

DO - 10.1016/j.radonc.2007.11.031

M3 - Article

C2 - 18158195

AN - SCOPUS:41949129417

VL - 87

SP - 127

EP - 131

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 1

ER -